NEW YORK (GenomeWeb) – CareDx said after the close of the market on Tuesday that its first quarter revenues grew 22 percent year over year. 

For the three months ended March 31, the Brisbane, California-based molecular diagnostics firm posted $7.2 million in revenues, up from $5.9 million in Q1 2014, and beating the consensus Wall Street estimate of $6.8 million. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.

A new study of a β-thalassemia gene therapy appears promising, according to NPR.

In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.

Futurism writes that gene doping could be the next generation of cheating in sports.